Ristocetin-Induced Platelet Aggregation (RIPA) and RIPA Mixing Studies.
Frontroth JP, Favaloro EJ.
Methods Mol Biol. 2017;1646:473-494. doi: 10.1007/978-1-4939-7196-1_35.
Reduction of ristocetin-induced platelet aggregation (RIPA) during storage despite plasma renewal: evidence for hemostatic importance of GPIbalpha shedding.
Hosseini E, Taherabadi E, Rajabi A, Ghasemzadeh M.
Expert Rev Hematol. 2024 Jul;17(7):391-403. doi: 10.1080/17474086.2024.2370557. Epub 2024 Jun 21.
Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib.
Kazianka L, Drucker C, Skrabs C, Thomas W, Melchardt T, Struve S, Bergmann M, Staber PB, Porpaczy E, Einberger C, Heinz M, Hauswirth A, Raderer M, Pabinger I, Thalhammer R, Egle A, Wendtner CM, Follows G, Hoermann G, Quehenberger P, Jilma B, Jaeger U.
Leukemia. 2017 May;31(5):1117-1122. doi: 10.1038/leu.2016.316. Epub 2016 Nov 2.
Racial differences in ristocetin-induced platelet aggregation.
Buchanan GR, Holtkamp CA, Levy EN.
Br J Haematol. 1981 Nov;49(3):455-64. doi: 10.1111/j.1365-2141.1981.tb07249.x.
A plasma inhibitor of ristocetin-induced platelet aggregation in patients with sickle hemoglobinopathies.
Leichtman DA, Brewer GJ.
Am J Hematol. 1977;2(3):251-8. doi: 10.1002/ajh.2830020307.
Whole blood ristocetin-induced platelet impedance aggregometry does not reflect clinical severity in patients with type 1 von Willebrand disease.
Nakajima Y, Nogami K, Yada K, Ogiwara K, Furukawa S, Shimonishi N, Shima M.
Haemophilia. 2019 May;25(3):e174-e179. doi: 10.1111/hae.13725. Epub 2019 Mar 13.
Platelet-collagen adhesion enhances platelet aggregation induced by binding of VWF to platelets.
Laduca FM, Bell WR, Bettigole RE.
Am J Physiol. 1987 Nov;253(5 Pt 2):H1208-14. doi: 10.1152/ajpheart.1987.253.5.H1208.
Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
Grainick HR, Williams SB, McKeown LP, Rick ME, Maisonneuve P, Jenneau C, Sultan Y.
J Clin Invest. 1985 Oct;76(4):1522-9. doi: 10.1172/JCI112132.
Proceedings: Inhibition of ristocetin-induced platelet aggregation (RIPA) by Haemaccel and fibrinogen.
Stibbe J, Kirby E.
Thromb Diath Haemorrh. 1975 Nov 15;34(2):583.
Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children.
Frontroth JP, Hepner M, Sciuccati G, Feliú Torres A, Pieroni G, Bonduel M.
Thromb Haemost. 2010 Dec;104(6):1158-65. doi: 10.1160/TH10-04-0213. Epub 2010 Oct 12.
